AIM ImmunoTech Amends Bylaws on Stockholder Voting Standard

AIM ImmunoTech Inc.'s Board of Directors approved an amendment to its Amended and Restated Bylaws, effective June 9, 2026. This amendment revises the voting standard for stockholder proposals, excluding the election of directors. The new standard dictates that proposals will be determined by the affirmative vote of a majority of votes cast, specifically excluding abstentions and broker non-votes, a change from the previous requirement of a majority in voting power of shares present and entitled to vote.